Semen News and Research

RSS

Semen is an organic fluid, also known as seminal fluid, that usually contains spermatozoa. It is secreted by the gonads (sexual glands) and other sexual organs of male or hermaphroditic animals and can fertilize female ova. The process of discharge is called ejaculation.

New microbicide may block AIDS virus from infecting cells

University of Utah researchers have discovered a new class of compounds that stick to the sugary coating of the AIDS virus and inhibit it from infecting cells - an early step toward a new treatment to prevent sexual transmission of the virus.

23 Sep 2011

Sperm bank spurns potential redhead donors

Cryos International, one of the world's largest sperm banks is refusing potential donors who have red hair. The bank's director told the Danish newspaper Ekstrabladet that there simply wasn't much demand for sperm from red-headed men.

20 Sep 2011

UCLA develops dual-mode microscope that uses holograms instead of lenses

To serve remote areas of the world, doctors, nurses and field workers need equipment that is portable, versatile, and relatively inexpensive. Now researchers at the University of California at Los Angeles (UCLA) have built a compact, light-weight, dual-mode microscope that uses holograms instead of lenses.

31 Aug 2011

Antioxidants may help treat infertility problems in both women and men

A growing body of evidence suggests that antioxidants may have significant value in addressing infertility issues in both women and men, including erectile dysfunction, and researchers say that large, specific clinical studies are merited to determine how much they could help.

29 Jul 2011

Fiscal problems could be mitigated by ART conceived children

In 2009, 1,547 ART children were born in public clinics in Denmark, projecting a net tax revenue of -224 million and -247 million in 25 and 50 years respectively. The authors of the study calculated that reductions of 30-50% in ART cycles following the new policy would lead to cost savings of -67 - -111 million for the Danish government in 2034.

6 Jul 2011

Research offers avenue for creating Alzheimer's and HIV therapeutics

A new advance by UCLA biochemists has brought scientists one step closer to developing treatments that could delay the onset of Alzheimer's disease and prevent the sexual transmission of HIV.

24 Jun 2011

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Celgene International Sàrl announced that clinical data from a Phase II study, conducted by investigators from the MD Anderson Cancer Center in Houston, TX, evaluating the combination regimen of REVLIMID plus rituximab (R2) in untreated, advanced stage, indolent B-cell non-Hodgkin's lymphomas, were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

18 Jun 2011

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Celgene International Sarl today announced a collaboration to conduct an international randomized study to evaluate the therapeutic potential of the REVLIMID/rituximab combination regimen (R2) in patients with newly diagnosed follicular lymphoma.

17 Jun 2011

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Celgene International Sàrl announced that clinical data from two studies evaluating the use of REVLIMID® (lenalidomide) with standard R-CHOP chemotherapy in patients with untreated diffuse large B cell (DLBCL) or grade 3 follicular lymphoma were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

17 Jun 2011

Celgene announces results of REVLIMID, docetaxel/prednisone phase II combination study on mCRPC

Celgene International Sàrl today announced results from a phase II investigator initiated study of REVLIMID (lenalidomide) in combination with Avastin (bevacizumab), docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, Ill.

6 Jun 2011

Queen's University develops groundbreaking new test for male infertility

A groundbreaking new test for male infertility, which will save time, money and heartache for couples around the world, has been developed at Queen's University Belfast.

6 Jun 2011

SpermComet: New test for male infertility

A new test for male infertility will save time, money and heartache for couples around the world, scientists have claimed. Queen's University Belfast said that more than a decade's research by Professor Sheena Lewis, who leads its Reproductive Medicine research group, had delivered a medical breakthrough.

5 Jun 2011

Study shows positive link between percentage of motile sperm and serum vitamin D levels

Vitamin D is important for optimal reproductive function in both animals and humans. It has long been known that serum vitamin D level is important for reproductive function in various animals, but now researchers from the University of Copenhagen and Copenhagen University Hospital have shown that this relationship can also be demonstrated in humans.

26 May 2011

Offensive editorial leads to resignation of the president-elect of the American College of Surgeons

The president-elect of the American College of Surgeons had to resign from his position Sunday after weeks of controversy surrounding a Valentine’s Day editorial he wrote speaking of the mood-enhancing effects of semen on women during unprotected sex.

20 Apr 2011

Prostatic artery embolization comparable to transurethral resection

A new interventional radiology treatment that blocks blood supply to men's enlarged prostate glands shows comparable clinical results to transurethral resection of the prostate (or TURP), considered the gold standard (or most common) treatment. However, this minimally invasive treatment-prostatic artery embolization-has none of the risks associated with TURP, such as sexual dysfunction, urinary incontinence, blood loss and retrograde ejaculation, noted researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago.

30 Mar 2011

Organochloride pesticide exposure can alter semen quality in young people

Two in 10 young people in South East Spain have poor sperm density, which involves requiring more time to accomplish fertilization. The most common means of exposure to pesticides is food and other household products.

23 Mar 2011

Nationwide observance raises awareness about HIV/AIDS spread in women

National Women and Girls AIDS Awareness Day, a nationwide observance that raises awareness and promotes action in the fight against HIV/AIDS, took place on March 10.

17 Mar 2011

TESE offers fertility to male cancer survivors

An intricate procedure that finds and carefully removes individual sperm from testicular tissue has made fathers of men who were once considered sterile due to prior cancer treatment, say researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center who pioneered the technique.

16 Mar 2011

TESE surgical technique can help men with childhood cancer experience parenthood

A new study has shown that a surgical technique called microdissection testicular sperm extraction can effectively locate and extract viable sperm in more than one-third of adult male childhood cancer survivors who were previously considered sterile due to prior chemotherapy treatment.

15 Mar 2011

5a-reductase inhibitors for male health problems can affect sexual health

A new study published in The Journal of Sexual Medicine reveals that, for the first time, 5a-reductase inhibitors commonly used to treat urinary problems in patients with benign prostatic hyperplasia (BPH) and found in popular medications to treat hair loss, can produce, persistent erectile dysfunction (ED), depression and loss of libido, even after the medication has been discontinued.

7 Mar 2011